Baird Financial Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Baird Financial Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,803	Closed	-$446K	–	1370
2015 Q2	$446K	Buy	+10,803	New	+$387K	﹤0.01%	999

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Baird Financial Group's BRLI Position: Q3 2015 in Review

Baird Financial Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 10,803 shares — an estimated $446K sold.

Baird Financial Group first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $446K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Baird Financial Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Baird Financial Group sold 10,803 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $446K.
Baird Financial Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
Baird Financial Group's BIO-REFERENCE LABS INC-NEW- position peaked at $446K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Baird Financial Group's 13F filing for Q3 2015, filed 12 Nov 2015.